骨髓增殖性肿瘤中NFE2过表达的表观遗传调控
本文研究骨髓增殖性肿瘤(MPN)中转录因子NFE2过表达的表观遗传机制,发现组蛋白去甲基化酶JMJD1C是NFE2的新靶基因,且JMJD1C与NFE2形成新的自身调节环路;NFE2还通过JAK2通路磷酸化H3Y41受表观调控,地西他滨处理可降低H3Y41ph并增加H3K9me2水平,从而在JAK2V617F阳性细胞系中选择性恢复正常NFE2表达。
要点
- JMJD1C是NFE2的新靶基因,在PV和PMF患者中显著升高伴整体H3K9me1和H3K9me2水平显著降低。
- PV患者中JMJD1C与NFE2启动子结合增加,降低H3K9me2水平和抑制性异染色质蛋白1α(HP1α)结合。
- 地西他滨处理HEL细胞降低H3Y41ph并增加NFE2位点H3K9me2水平,在JAK2V617F阳性细胞系中选择性恢复正常NFE2表达。
核心结论
- JMJD1C构成NFE2的新靶基因,JMJD1C与NFE2参与新的自身调节环路。
- NFE2还通过表观遗传JAK2通路经H3Y41磷酸化调控,抑制HP1α结合。
- 地西他滨处理可降低H3Y41ph并增加H3K9me2水平,在JAK2V617F阳性细胞系中选择性恢复正常NFE2表达。
研究设计与样本
- 本文为实验研究,涉及MPN患者样本、小鼠模型和MPN细胞系。
- 研究对象包括真性红细胞增多症(PV)和原发性骨髓纤维化(PMF)患者。
- 实验包括组蛋白修饰水平检测、染色质免疫沉淀、基因敲低和药物处理。
主要发现
- JMJD1C水平在PV和PMF患者中显著升高,同时整体H3K9me1和H3K9me2水平显著降低。
- PV患者中JMJD1C与NFE2启动子结合增加,降低H3K9me2水平和HP1α结合。
- 敲低JMJD1C表达显著降低MPN细胞系的细胞因子非依赖性生长。
- 地西他滨处理HEL细胞降低H3Y41ph并增加NFE2位点H3K9me2水平,增加HP1α结合,在JAK2V617F阳性细胞系中选择性恢复正常NFE2表达。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The transcription factor "nuclear factor erythroid 2" (NFE2) is overexpressed in the majority of patients with myeloproliferative neoplasms (MPNs). In murine models, elevated NFE2 levels cause an MPN phenotype with spontaneous leukemic transformation. However, both the molecular mechanisms leading to NFE2 overexpression and its downstream targets remain incompletely understood. Here, we show that the histone demethylase JMJD1C constitutes a novel NFE2 target gene. JMJD1C levels are significantly elevated in polycythemia vera (PV) and primary myelofibrosis patients; concomitantly, global H3K9me1 and H3K9me2 levels are significantly decreased. JMJD1C binding to the NFE2 promoter is increased in PV patients, decreasing both H3K9me2 levels and binding of the repressive heterochromatin protein-1α (HP1α). Hence, JMJD1C and NFE2 participate in a novel autoregulatory loop. Depleting JMJD1C expression significantly reduced cytokine-independent growth of an MPN cell line. Independently, NFE2 is regulated through the epigenetic JAK2 pathway by phosphorylation of H3Y41. This likewise inhibits HP1α binding. Treatment with decitabine lowered H3Y41ph and augmented H3K9me2 levels at the NFE2 locus in HEL cells, thereby increasing HP1α binding, which normalized NFE2 expression selectively in JAK2V617F-positive cell lines.
引用
- Peeken JC, Jutzi JS, Wehrle J, et al. Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasms. Blood. 2018. PMID: 29519804. doi:10.1182/blood-2017-10-810622
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。